Commodore Capital’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-750,000	Closed	-$3.1M	–	38
2022 Q4	$3.1M	Hold	750,000	–	–	0.47%	30
2022 Q3	$2.4M	Buy	+750,000	New	+$2.4M	0.39%	29